Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFih Group Regulatory News (FIH)

Share Price Information for Fih Group (FIH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 220.00
Bid: 210.00
Ask: 230.00
Change: 0.00 (0.00%)
Spread: 20.00 (9.524%)
Open: 220.00
High: 220.00
Low: 220.00
Prev. Close: 220.00
FIH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - FIH Group plc - Amendment

16 Mar 2017 12:38

FORM 8.3

AMENDMENT TO REPLACE FORM 8.3 PUBLISHED ON MARCH 9, 2017.

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Dolphin Fund Ltd.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

E. Elsztain
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

FIH Group plc (the “Offeree”)
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

16 March 2017
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary Shares

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 315,609 2.54% Nil -
(2) Cash-settled derivatives: Nil - Nil -
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: Nil - Nil -

TOTAL:

315,609 2.54% Nil -

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: N/A
Details, including nature of the rights concerned and relevant percentages: N/A

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 16 Mar. 17
Contact name: Carolina Zang
Telephone number: Tel.: (+54 11) 4323-4000

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170316005740/en/

Copyright Business Wire 2017

Date   Source Headline
17th Jan 20247:00 amRNSBlock listing Interim Review
24th Nov 20237:00 amRNSResults for the Six Months Ended 30 September 2023
28th Sep 20233:52 pmRNSResults of Annual General Meeting
28th Sep 20237:00 amRNSAGM Statement
15th Sep 202311:30 amRNSDividend Timetable
31st Aug 20231:15 pmRNSPosting of Annual Report and Notice of AGM
11th Aug 20237:00 amRNSDirectorate Change
7th Aug 20237:00 amRNSFinal Results
17th Jul 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
26th May 20238:57 amRNSDirectorate Change
5th May 202312:15 pmRNSFull Year Trading Update
13th Apr 20232:31 pmRNSChange of Auditor
15th Mar 202310:28 amRNSBlock listing Interim Review
24th Feb 20237:00 amRNSDirectorate Change
6th Dec 20227:00 amRNSDirector and PDMR Dealings
22nd Nov 20222:43 pmRNSTR1: Form for notification of major holdings
22nd Nov 20227:00 amRNSTR-1: Form for notification of major holdings
21st Nov 20227:00 amRNSResults for the Six Months Ended 30 September 2022
27th Sep 20229:40 amRNSDividend Timetable
20th Sep 20224:36 pmRNSDirector Resignation
20th Sep 20224:32 pmRNSResult of AGM
20th Sep 20227:00 amRNSAGM Statement
13th Sep 202211:02 amRNSAGM Postponement to Tuesday 20 September 2022
26th Aug 20227:00 amRNSPosting of Annual Report & Notice of AGM
8th Aug 202212:14 pmRNSDirector and PDMR Dealings
21st Jul 20222:21 pmRNSDividend Announcement
18th Jul 20227:00 amRNSBlock Listing Interim Review
18th Jul 20227:00 amRNSBlock listing Interim Review
7th Jul 20227:00 amRNSAppointment of Chief Financial Officer
5th Jul 20227:00 amRNSFinal Results
10th May 20227:00 amRNSFull Year Trading Update
9th May 20226:10 pmRNSDirector's Details
17th Dec 20214:39 pmRNSDirector and PDMR Dealings
13th Dec 202111:37 amRNSDirector and PDMR Dealings
6th Dec 20217:00 amRNSIssue of share awards and Director/PDMR dealings
3rd Dec 20219:13 amRNSReplacement - PDMR Dealing
3rd Dec 20217:00 amRNSPDMR Dealing
23rd Nov 20217:00 amRNSDirectorate Change
18th Nov 20217:00 amRNSNew £17.3m Housing Contract in the Falklands
10th Nov 20217:00 amRNSResults for the Six Months Ended 30 September 2021
5th Oct 20215:05 pmRNSHolding(s) in Company
5th Oct 20215:02 pmRNSHolding(s) in Company
9th Sep 20212:25 pmRNSResult of AGM
9th Sep 20217:00 amRNSAGM Statement
16th Aug 20214:34 pmRNSPosting of Annual Report & Notice of AGM
28th Jul 20212:12 pmRNSDirector/PDMR Shareholding
16th Jul 20212:38 pmRNSBlock listing Interim Review
8th Jul 20218:40 amRNSDirector and PDMR dealing
6th Jul 20217:00 amRNSFinal Results
28th Apr 20217:00 amRNSAppointment of Chief Financial Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.